Table of Contents Author Guidelines Submit a Manuscript
Volume 8, Pages 164-165
Clinical Image

Nephrogenic Fibrosing Dermopathy

Division of Nephrology, St. John Hospital and Medical Center, Detroit, MI, USA

Received 12 December 2007; Accepted 12 December 2007

Academic Editor: Daniel Batlle

Copyright © 2008 Ashish Dhungel et al.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Frank G. Shellock, and Alberto Spinazzi, “MRI safety update 2008: Part 1, MRI contrast agents and nephrogenic systemic fibrosis,” American Journal of Roentgenology, vol. 191, no. 4, pp. 1129–1139, 2008. View at Publisher · View at Google Scholar
  • Andrew J. Gauden, Pramit M. Phal, and Katharine J. Drummond, “MRI safety; nephrogenic systemic fibrosis and other risks,” Journal of Clinical Neuroscience, vol. 17, no. 9, pp. 1097–1104, 2010. View at Publisher · View at Google Scholar
  • Rabi Yacoub, Kiran Kandukurti, and Mandip Panesar, “Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis,” ISRN Transplantation, vol. 2013, pp. 1–10, 2013. View at Publisher · View at Google Scholar